1st Edition

Nanomedicine in Cancer

Edited By Lajos Balogh Copyright 2017
    840 Pages 56 Color & 118 B/W Illustrations
    by Jenny Stanford Publishing

    840 Pages 56 Color & 118 B/W Illustrations
    by Jenny Stanford Publishing

    This book is the first in a series compiling highly cited articles in nanomedicine recently. The series is edited by Lajos P. Balogh, a prominent nanotechnology researcher and journal editor. The first book content is about nanotechnology in cancer research. It also includes a wide variety of must-know topics that will appeal to any researcher involved in nanomedicine, macromolecular science, cancer therapy, and drug delivery research. These 31 articles collected here have already acquired more than 3500 citations (i.e., over a hundred on average), highlighting the importance and recognized professional interest of the scientists working in this field.

    Nanotechnology Platforms and Physiological Challenges for Cancer Therapeutics
    Kelly Y. Kim

    Nanostructure-Mediated Drug Delivery
    Gareth A. Hughes

    Nanoparticles: A Boon to Drug Delivery, Therapeutics, Diagnostics and Imaging
    Suphiya Parveen, Ranjita Misra, and Sanjeeb K. Sahoo

    Emerging Nanopharmaceuticals
    Dhruba J. Bharali, Willie E. Bawarski, Elena Chidlowsky, and Shaker A. Mousa

    Significance of Synthetic Nanostructures in Dictating Cellular Response
    Evelyn K. F. Yim and Kam W. Leong

    Electrospun Bioscaffolds That Mimic the Topology of Extracellular Matrix
    Dong Han and Pelagia-Irene Gouma

    Preparation of Drug-Loaded Polymeric Nanoparticles
    Catarina Pinto Reis, Ronald J. Neufeld, Francisco Veiga, and António J. Ribeiro

    In vivo Tumor Suppression Efficacy of Mesoporous Silica Nanoparticle-Based Drug Delivery System: Enhanced Efficacy by Folate Modification
    Jie Lu, Zongxi Li, Jeffrey I. Zink, and Fuyuhiko Tamanoi

    Update on Nanoparticle-Mediated Immune Mechanisms for Dendritic Cell-Based Targeted Immunity and Cancer
    Soledad Lopez, Rebecca Klippstein, and David Pozo

    Curcumin-Loaded γ-Cyclodextrin Liposomal Nanoparticles as Delivery Vehicles for Osteosarcoma
    Santosh S. Dhule, Patrice Penfornis, Trivia Frazier, Ryan Walker, Joshua Feldman, Grace Tan, Jibao He, Alina Alb, Vijay John, and Radhika Pochampally

    Influence of Purity and Surface Oxidation on Cytotoxicity of Multiwalled Carbon Nanotubes with Human Neuroblastoma Cells
    Orazio Vittorio, Vittoria Raffa, and Alfred Cuschieri

    Hollow Chitosan-Alginate Multilayer Microcapsules as Drug Delivery Vehicle: Doxorubicin Loading and in vitro and in vivo Studies
    Qinghe Zhao, Baosan Han, Zhaohai Wang, Changyou Gao, Chenghong Peng, and Jiacong Shen

    ZnO Nanorod-Induced Apoptosis in Human Alveolar Adenocarcinoma Cells via p53, Survivin and bax/bcl-2 Pathways: Role of Oxidative Stress
    Maqusood Ahamed, Mohd Javed Akhtar, Mohan Raja, Iqbal Ahmad, Mohammad Kaleem Javed Siddiqui, Mohamad S. AlSalhi, and Salman A. Alrokayan

    Camptothecin in Sterically Stabilized Phospholipid Micelles: A Novel Nanomedicine
    Otilia M. Koo, Israel Rubinstein, and Hayat Onyuksel

    Photoablation of Glioblastoma Stem Cells by Single-Walled Carbon Nanotubes Functionalized with CD133 Antibody
    Chung-Hao Wang, Shih-Hwa Chiou, Chen-Pin Chou, Yu-Chih Chen, Yao-Jhang Huang, and Ching-An Peng

    Surface Chemistry Influences Cancer Killing Effect of TiO2 Nanoparticles
    Paul Thevenot, Jai Cho, Dattatray Wavhal, Ashwin Nair, Richard B. Timmons, and Liping Tang

    Endocytosis of Titanium Dioxide Nanoparticles in Prostate Cancer PC-3M Cells
    Kenneth T. Thurn, Hans Arora, Tatjana Paunesku, Aiguo Wu, Eric M. B. Brown, Caroline Doty, Jeff Kremer, and Gayle Woloschak

    Multi-Walled Carbon Nanotube Exposure Alters Protein Expression in Human Keratinocytes
    Frank A. Witzmann and Nancy A. Monteiro-Riviere

    Carbon Nanotubes as Functional Excipients for Nanomedicines: I. Drug Delivery and Biocompatibility Issues
    Marianna Foldvari and Mukasa Bagonluri

    Carbon Nanotubes as Functional Excipients for Nanomedicines: II. Pharmaceutical Properties
    Marianna Foldvari and Mukasa Bagonluri

    Fluorescence Intensity and Lifetime Imaging of Free and Micellar-Encapsulated Doxorubicin in Living Cells
    Xiaowen Dai, Zhilian Yue, Mark E. Eccleston, Johannes Swartling, Nigel K. H. Slater, and Clemens F. Kaminski

    Doxorubicin-Loaded Solid Lipid Nanoparticles to Overcome Multidrug Resistance in Cancer Therapy
    Keon Wook Kang, Myung-Kwan Chun, Ok Kim, Robhash Kusam Subedi, Sang-Gun Ahn, Jung-Hoon Yoon, and Hoo-Kyun Choi

    PEGylated PLGA Nanoparticles for the Improved Delivery of Doxorubicin
    Jason Park, Peter M. Fong, Jing Lu, Kerry S. Russell, Carmen J. Booth, W. Mark Saltzman, and Tarek M. Fahmy

    Gold--Doxorubicin Nanoconjugates for Overcoming Multidrug Resistance
    Jinping Cheng, Yan-Juan Gu, Cornelia Wing-Yin Man, Wing-Tak Wong, and Shuk Han Cheng

    In vitro Evaluation of Novel Polymer-Coated Magnetic Nanoparticles for Controlled Drug Delivery
    Maham Rahimi, Aniket Wadajkar, Khaushik Subramanian, Monet Yousef, Weina Cui, Jer-Tsong Hsieh, and Kytai Truong Nguyen

    Targeting of Albumin-Embedded Paclitaxel Nanoparticles to Tumors
    Priya Prakash Karmali, Venkata Ramana Kotamraju, Mark Kastantin, Matthew Black, Dimitris Missirlis, Matthew Tirrell, and Erkki Ruoslahti

    Viral Nanoparticles as Platforms for Next-Generation Therapeutics and Imaging Devices
    Nicole F. Steinmetz

    Beta-Casein Nanovehicles for Oral Delivery of Chemotherapeutic Drugs
    Alina Shapira, Yehuda G. Assaraf, and Yoav D. Livney

    Classification of Lung Cancer Histology by Gold Nanoparticle Sensors
    Orna Barash, Nir Peled, Ulrike Tisch, Paul A. Bunn Jr., Fred R. Hirsch, and Hossam Haick

    Enhancement of Radiation Effects by Gold Nanoparticles for Superficial Radiation Therapy
    Wan Nordiana Rahman, Nour Bishara, Trevor Ackerly, Cheng Fa He, Price Jackson, Christopher Wong, Robert Davidson, and Moshi Geso

    Radioactive Gold Nanoparticles in Cancer Therapy: Therapeutic Efficacy Studies of GA-198AuNP Nanoconstruct in Prostate Tumor--Bearing Mice
    Nripen Chanda, Para Kan, Lisa D. Watkinson, Ravi Shukla, Ajit Zambre, Terry L. Carmack, Hendrik Engelbrecht, John R. Lever, Kavita Katti, Genevieve M. Fent, Stan W. Casteel, C. Jeffrey Smith, William H. Miller, Silvia Jurisson, Evan Boote, J. David Robertson, Cathy Cutler, Marina Dobrovolskaia, Raghuraman Kannan, and Kattesh V. Katti

    The Present and Future of Nanotechnology in Human Health Care
    S. K. Sahoo, S. Parveen, and J. J. Panda

    Biography

    Lajos P. Balogh, PhD, is the owner and chief scientific advisor of AA Nanomedicine & Nanotechnology, a consulting firm registered in Essex County, Massachusetts, USA. He also serves as the executive editor of Manuscript Clinic (www.manuscriptclinic.us) and supports scientists and students to successfully publish their research results in the field of nanomedicine and nanotechnology. Dr. Balogh was the editor-in-chief of Nanomedicine: Nanotechnology, Biology and Medicine for seven years and transformed the journal to a highly respected professional publication. He held faculty positions at Kossuth University, Debrecen, Hungary; University of Massachusetts Lowell, Massachusetts; Michigan Molecular Institute, Midland, Michigan; University of Michigan, Ann Arbor, Michigan; Roswell Park Cancer Institute, Buffalo, New York; and Northeastern University, Boston, Massachusetts. He has published 219 scientific papers, has given more than 250 invited lectures, and has been awarded 12 patents. Dr. Balogh has 14 papers with more than 100 citations and 6 with more than 200 citations in nanomedicine. He is one of the five founders of the American Society for Nanomedicine and a board member of many international scientific organizations.